Pluri logo

Pluri share price today

(PLUR)

Pluri share price is $4.6 & ₹392.24 as on 27 Dec 2024, 2.30 'hrs' IST

$4.6

0.15

(3.37%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Pluri share price in Dollar and Rupees. Guide to invest in Pluri from India. Also see the sentimental analysis on Indian investors investing in Pluri. Get details on the Indian mutual funds that are investing in Pluri. Get Analyst recommendations and forecasts along with all the Pluri's financials.

Pluri share price movements

  • Today's Low: $4.37
    Today's High: $4.63

    Day's Volatility :5.58%

  • 52 Weeks Low: $4.16
    52 Weeks High: $8.48

    52 Weeks Volatility :50.94%

Pluri Returns

PeriodPluri IncIndex (Russel 2000)
3 Months
-26.81%
0.0%
6 Months
-23.01%
0.0%
1 Year
-4.09%
0.0%
3 Years
-42.66%
-21.1%

Pluri Key Statistics

in dollars & INR

Previous Close
$4.45
Open
$4.37
Today's High
$4.6281
Today's Low
$4.37
Market Capitalization
$24.7M
Today's Volume
$4.3K
52 Week High
$8.48
52 Week Low
$4.16
Revenue TTM
$326.0K
EBITDA
$-21.9M
Earnings Per Share (EPS)
$-4.11
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-206.07%

How to invest in Pluri from India?

It is very easy for Indian residents to invest directly in Pluri from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pluri stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pluri or PLUR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pluri or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pluri shares which would translate to 0.185 fractional shares of Pluri as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pluri, in just a few clicks!

Returns in Pluri for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pluri investment value today

Current value as on today

₹1,01,463

Returns

₹1,463

(+1.46%)

Returns from Pluri Stock

₹862 (-0.86%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Pluri

33%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Pluri on INDmoney from India has grown in the last 30 days as on Dec 27, 2024. 33% more investors are searching Pluri in the last 30 days versus the previous period.

Global Institutional Holdings in Pluri

  • Renaissance Technologies Corp

    0.44%

  • Values First Advisors Inc

    0.25%

  • Jane Street Group LLC

    0.22%

  • Zurcher Kantonalbank

    0.03%

  • UBS Group AG

    0.02%

  • Morgan Stanley - Brokerage Accounts

    0.01%

Analyst Recommendation on Pluri

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Pluri(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Pluri

What analysts predicted

Downside of 13.04%

Current:

$4.60

Target:

$4.00

Insights on Pluri

  • Price Movement

    In the last 1 month, PLUR stock has moved down by -17.6%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 71.0K → 326.0K (in $), with an average increase of 48.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 5 quarters, 279.0K → -5.88M (in $), with an average decrease of 476.7% per quarter
  • PLUR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 20.2%
  • Price to Sales

    ForPLUR every $1 of sales, investors are willing to pay $71.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Pluri Technicals Summary

Sell

Neutral

Buy

Pluri is currently in a neutral trading position according to technical analysis indicators.

Pluri Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pluri Inc
-20.11%
-23.01%
-4.09%
-42.66%
-42.66%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.02%
-18.97%
11.91%
91.19%
Biontech Se
-3.72%
42.02%
7.95%
-52.72%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
0.1%
24.29%
44.19%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-12.92%
-0.27%
83.92%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pluri Inc
NA
NA
NA
-0.33
-2.06
-0.31
NA
0.02
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pluri Inc
Buy
$24.7M
-42.66%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Pluri

pluristem therapeutics inc. (nasdaqcm: psti, tase: psti/pltr) is a clinical-stage biotherapy company using placental cells and a unique, proprietary, three-dimensional (3d) technology platform to develop cell therapies for conditions such as inflammation, ischemia, hematological disorders, or exposure to radiation. pluristem’s placental expanded (plx) cells are placenta-derived, mesenchymal-like adherent stromal cells that are designed to be administered to patients without the need for tissue or genetic matching. these cells release soluble biomolecules, such as cytokines, chemokines and growth factors, which act in a paracrine or endocrine manner to facilitate healing of damaged tissues by stimulating the body’s own regenerative mechanisms. the company’s proprietary, 3d expansion technology can be used to grow plx cells in mass quantities with batch-to-batch consistency at pluristem’s fda, ema and pmda-approved, state-of-the art manufacturing facility. pluristem’s first product candi
Organization
Pluri
Employees
106
CEO
Mr. Yaacov Yanay
Industry
Miscellaneous

Management People of Pluri

NameTitle
Mr. Yaacov Yanay
President, CEO & Director
Ms. Liat Zalts
Chief Financial Officer & Treasurer
Mr. Lior Raviv
Chief Technology Officer
Dr. Arthur Machlenkin Ph.D.
Chief Scientific Officer
Ms. Efrat Livne-Hadass
Chief Wellbeing Officer
Ms. Orly Amiran
Chief Quality Officer
Ms. Efrat Kaduri
Chief Business Development Officer of Pharma
Mr. Nimrod Bar Zvi
Chief Commercial Officer
Mr. John Dvor
EVP North America

Important FAQs about investing in Pluri from India :

What is Pluri share price today?

Pluri share price today stands at $4.60, Open: $4.37 ; Previous Close: $4.45 ; High: $4.63 ; Low: $4.37 ; 52 Week High: $8.48 ; 52 Week Low: $4.16. The stock opens at $4.37, after a previous close of $4.45. The stock reached a daily high of $4.63 and a low of $4.37, with a 52-week high of $8.48 and a 52-week low of $4.16.

Can Indians buy Pluri shares?

Yes, Indians can invest in the Pluri (PLUR) from India.

With INDmoney, you can buy Pluri at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pluri at zero transaction cost.

How can I buy Pluri shares from India?

It is very easy to buy Pluri from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pluri be purchased?

Yes, you can buy fractional shares of Pluri with INDmoney app.

What are the documents required to start investing in Pluri stocks?

To start investing in Pluri, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pluri

Today’s highest price of Pluri (PLUR) is $4.63.

Today’s lowest price of Pluri (PLUR) is $4.37.

What is today's market capitalisation of Pluri

Today's market capitalisation of Pluri PLUR is 24.7M

What is the 52 Week High and Low Range of Pluri

  • 52 Week High

    $8.48

  • 52 Week Low

    $4.16

What are the historical returns of Pluri?

  • 1 Month Returns

    -20.11%

  • 3 Months Returns

    -23.01%

  • 1 Year Returns

    -4.09%

  • 5 Years Returns

    -42.66%

Who is the Chief Executive Officer (CEO) of Pluri

Mr. Yaacov Yanay is the current Chief Executive Officer (CEO) of Pluri.